What is the current Global Oncolytic Virotherapy Market size?

The Global Oncolytic Virotherapy Market is projected to register a CAGR of 22.87% during the forecast period (2024-2029) Read More

Who are the key players in Global Oncolytic Virotherapy Market?

Transgene SA, Sorrento Therapeutics, Inc., Amgen, CG Oncology Inc and Oncolys BioPharma are the major companies operating in the Global Oncolytic Virotherapy Market. Read More

Which is the fastest growing region in Global Oncolytic Virotherapy Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Oncolytic Virotherapy Market?

In 2024, the North America accounts for the largest market share in Global Oncolytic Virotherapy Market. Read More

What years does this Global Oncolytic Virotherapy Market cover?

The report covers the Global Oncolytic Virotherapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Oncolytic Virotherapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Oncolytic Virotherapy Market

Oncolytic Virotherapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Oncolytic Virotherapy Market is segmented by types (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Others), application (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer and Others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).

Oncolytic Virotherapy Industry Overview

The mounting rise in the cases of cancer around the globe has created a buzz among companies to invest in the advancement of technologies for treatment. The rising number of pipeline candidates and intense market penetration of the drugs have made oncolytic virotherapy a pioneer in the therapeutic field which leads the significant competition in the market. Some of the prominent market leaders in the global oncolytic virus therapy market are Amgen Inc., Shanghai Sunway Biotech Co., Ltd., TILT Biotherapeutics Ltd., and Oncorus, Inc., Takara Bio Inc., Vyriad, Transgene SA, Lokon Pharma AB, Pfizer Inc., and others.